Status:
WITHDRAWN
Engaging Patients and Providers in Collaborative Communication on HPV Vaccination (EPICC-HPV)
Lead Sponsor:
University of New Mexico
Collaborating Sponsors:
Klein Buendel, Inc.
Conditions:
Vaccine Decision Making
Eligibility:
All Genders
26+ years
Phase:
NA
Brief Summary
Vaccination against Human Papillomavirus is recommended for adolescent females by the Advisory Committee on Immunization Practices (ACIP), physicians, and many medical organizations, yet uptake of HPV...
Detailed Description
Uptake of the Human Papillomavirus (HPV) vaccines in the U.S. remains very low. (RQ-1) The quadrivalent HPV vaccine has been routinely recommended for adolescent females by the Advisory Committee on I...
Eligibility Criteria
Inclusion
- Parent of an adolescent girl ages 11-14, adolescent girl has not yet received HPV vaccination
Exclusion
- adolescent girl has received HPV vaccination
Key Trial Info
Start Date :
August 28 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 28 2017
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03267251
Start Date
August 28 2017
End Date
August 28 2017
Last Update
July 12 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.